scholarly article | Q13442814 |
P356 | DOI | 10.1093/JAT/34.9.594 |
P953 | full work available at URL | https://academic.oup.com/jat/article-pdf/34/9/594/2362367/34-9-594.pdf |
http://academic.oup.com/jat/article-pdf/34/9/594/2362367/34-9-594.pdf | ||
P698 | PubMed publication ID | 21073814 |
P5875 | ResearchGate publication ID | 47789248 |
P2093 | author name string | Gunilla Thelander | |
Robert Kronstrand | |||
Ingrid Nyström | |||
Maria Wikström | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | intoxication | Q18621601 |
drug testing | Q1260023 | ||
P304 | page(s) | 594-598 | |
P577 | publication date | 2010-11-01 | |
P1433 | published in | Journal of Analytical Toxicology | Q1709826 |
P1476 | title | Two Fatal Intoxications with the New Designer Drug Methedrone (4-Methoxymethcathinone) | |
P478 | volume | 34 |
Q38237555 | 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting. |
Q36441681 | 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry |
Q46193644 | An accidental fatal intoxication with methoxetamine |
Q93028640 | Case Series of Novel Illicit Opioid-Related Deaths |
Q37900939 | Cathinone derivatives: a review of their chemistry, pharmacology and toxicology |
Q39052269 | Clinical Pharmacology of the Synthetic Cathinone Mephedrone |
Q46187150 | Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays |
Q47614200 | Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples |
Q53364460 | Determination of designer drug cross-reactivity on five commercial immunoassay screening kits. |
Q28539324 | Dose and time-dependent selective neurotoxicity induced by mephedrone in mice |
Q33706892 | Emerging drugs of abuse: current perspectives on substituted cathinones |
Q45730203 | Identification and differentiation of methcathinone analogs by gas chromatography-mass spectrometry |
Q34079088 | Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish internet company |
Q55059127 | In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol. |
Q38169542 | Khat and synthetic cathinones: a review |
Q39208665 | Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice |
Q28276182 | NPS: Medical Consequences Associated with Their Intake |
Q53088893 | Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones. |
Q34474547 | Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching |
Q38850097 | Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases |
Q88361885 | The Designer Drug 3-Fluoromethcathinone Induces Oxidative Stress and Activates Autophagy in HT22 Neuronal Cells |
Q28253719 | The toxicology of bath salts: a review of synthetic cathinones |
Q40620922 | Thermal Degradation of Synthetic Cathinones: Implications for Forensic Toxicology |
Q40286882 | Three fatal intoxications due to methylone |
Q38254814 | Toxicology and management of novel psychoactive drugs |
Q33934379 | Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology |
Search more.